Added to YB: 2025-02-14
Pitch date: 2025-02-12
1SXP.F [neutral]
SCHOTT Pharma AG & Co. KGaA
-36.6%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide.
Market Cap
EUR 4.2B
Pitch Price
EUR 23.88
Price Target
N/A
Dividend
0.57%
EV/EBITDA
16.72
P/E
28.61
EV/Sales
4.62
Sector
Life Sciences Tools and Services
Category
turnaround
Schott Pharma (1SXP) Weak Start, Stronger Finish Expected
1SXP.F (overview): Q1 earnings drop due to mRNA headwinds & vial destocking. H2 recovery expected with new Hungary glass syringe production. Mid-term fundamentals intact. Trading at discount vs peers. Key: H2 recovery execution. Long-term attractive if turnaround succeeds.
Read full article (1 min)